Shanghai Xuerong Bio-Technology Co Ltd (300511) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Xuerong Bio-Technology Co Ltd (300511) has a cash flow conversion efficiency ratio of -0.036x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-62.35 Million ≈ $-9.12 Million USD) by net assets (CN¥1.71 Billion ≈ $250.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Shanghai Xuerong Bio-Technology Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Shanghai Xuerong Bio-Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Shanghai Xuerong Bio-Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See Shanghai Xuerong Bio-Technology Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
Shanghai Xuerong Bio-Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Xuerong Bio-Technology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Globalworth REIT
LSE:GWI
|
0.022x |
|
Beijing Mainstreets Investment
SHE:000609
|
-1.667x |
|
Guizhou Transp Planning
SHG:603458
|
0.028x |
|
Gyre Therapeutics Inc.
NASDAQ:GYRE
|
0.034x |
|
Ibotta, Inc.
NYSE:IBTA
|
0.066x |
|
Hyulim ROBOT Co.Ltd
KQ:090710
|
-0.070x |
|
Pareto Bank ASA
OL:PARB
|
-0.015x |
|
Sichuan Kexin Mechanic Electric
SHE:300092
|
0.018x |
Annual Cash Flow Conversion Efficiency for Shanghai Xuerong Bio-Technology Co Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Xuerong Bio-Technology Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Shanghai Xuerong Bio-Technology Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥823.32 Million ≈ $120.48 Million |
CN¥437.20 Million ≈ $63.98 Million |
0.531x | +112.56% |
| 2023-12-31 | CN¥1.43 Billion ≈ $209.60 Million |
CN¥357.84 Million ≈ $52.36 Million |
0.250x | +10.63% |
| 2022-12-31 | CN¥1.63 Billion ≈ $237.91 Million |
CN¥367.13 Million ≈ $53.72 Million |
0.226x | +51.42% |
| 2021-12-31 | CN¥1.65 Billion ≈ $242.11 Million |
CN¥246.75 Million ≈ $36.11 Million |
0.149x | -45.69% |
| 2020-12-31 | CN¥2.02 Billion ≈ $296.00 Million |
CN¥555.47 Million ≈ $81.28 Million |
0.275x | -18.60% |
| 2019-12-31 | CN¥1.74 Billion ≈ $254.60 Million |
CN¥586.93 Million ≈ $85.89 Million |
0.337x | +30.18% |
| 2018-12-31 | CN¥1.57 Billion ≈ $229.73 Million |
CN¥406.82 Million ≈ $59.53 Million |
0.259x | +11.68% |
| 2017-12-31 | CN¥1.42 Billion ≈ $207.26 Million |
CN¥328.64 Million ≈ $48.09 Million |
0.232x | -5.80% |
| 2016-12-31 | CN¥1.29 Billion ≈ $188.75 Million |
CN¥317.71 Million ≈ $46.49 Million |
0.246x | -42.15% |
| 2015-12-31 | CN¥642.99 Million ≈ $94.09 Million |
CN¥273.77 Million ≈ $40.06 Million |
0.426x | -11.06% |
| 2014-12-31 | CN¥529.00 Million ≈ $77.41 Million |
CN¥253.24 Million ≈ $37.06 Million |
0.479x | -11.72% |
| 2013-12-31 | CN¥433.49 Million ≈ $63.43 Million |
CN¥235.07 Million ≈ $34.40 Million |
0.542x | +84.31% |
| 2012-12-31 | CN¥381.15 Million ≈ $55.77 Million |
CN¥112.14 Million ≈ $16.41 Million |
0.294x | -- |
About Shanghai Xuerong Bio-Technology Co Ltd
Shanghai Xuerong Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research and development, cultivation and sale of fresh edible mushrooms in the People's Republic of China. It offers enoki mushrooms; shiitake mushrooms, including oyster mushrooms, white jade mushrooms and seafood mushrooms; king oyster mushrooms; and velvet mushrooms, as well as Pleurotus eryngii and Flammu… Read more